Particle.news
Download on the App Store
3 ARTICLES
·
4w ago

Biogen Announces Move to New Headquarters in Kendall Common

The Cambridge-based biotech will consolidate operations into a sustainable 580,000-square-foot facility set to open in 2028.

Street view of the planned Biogen headquarters at the corner of Kendall Square’s 6th Street Walkway and Broadway.
Image

Overview

  • Biogen's new headquarters at 75 Broadway will be the first private development in MIT's Kendall Common project, a 10-acre mixed-use innovation hub.
  • The facility will integrate Biogen's research, development, and commercialization teams to enhance collaboration and innovation.
  • This move aligns with Biogen's cost-cutting initiatives, reducing its local office footprint by 412,000 square feet across three buildings.
  • The building, jointly developed by MIT and BioMed Realty, will feature advanced sustainable design and conservation elements.
  • Scheduled to open in 2028, the move coincides with Biogen's 50th anniversary, reinforcing its commitment to the Massachusetts life sciences ecosystem.